Complete solution to support patient’s health vs SARS-CoV-2

Quantification of Immuno-status of patients after infection or vaccination

Chorus SARS-CoV-2 “Neutralizing” Ab

Quantitative determination of total antibodies IgG ,IgM and IgA

Standardized against the first WHO International Standard

Quick and reliable detection of viral antigen in
suspected Covid-19 patients

Chorus SARS-CoV-2 Antigen

Semi-Quantitative determination of antigen in nasopharyngeal swab

Complete panel for the identification of the
antibodies response

Chorus SARS-CoV-2 IgG, IgM, IgA and Screen Serum

Qualitative tests to screen the specific immunoglobulin levels during the different phase of the infection

  • Single-test devices

  • Easy and ready-to-use

  • No hidden costs

  • No waste of reagents

Foto Diesse Chorus Trio
Foto Diesse Chorus

Coronavirus disease

QUALITATIVE TEST ON SERUM SAMPLE

Chorus SARS-CoV-2 IgA

For the qualitative determination of IgA antibodies
anti-SARS-CoV-2 virus.
36 tests 81402

Chorus SARS-CoV-2 IgG

For the qualitative determination of IgG antibodies
anti-SARS-CoV-2 virus.
36 tests 81400

Chorus SARS-CoV-2 IgM

For the qualitative determination of IgM antibodies
anti-SARS-CoV-2 virus.
36 tests 81401

Chorus SARS-CoV-2 Screen Serum

For the qualitative determination of total antibodies
anti-SARS-CoV-2 virus as an aid in the determination of the immune
reaction to SARS-CoV-2.
36 tests 81406

SEMI - QUANTITATIVE TEST ON SWAB SAMPLE

Chorus SARS-CoV-2 Antigen

For the semi-quantitative determination of SARS-CoV-2 virus
in nasopharyngeal swab.

36 tests 81410

QUANTITATIVE TEST ON SERUM SAMPLE

Chorus SARS-CoV-2 “NEUTRALIZING” Ab

For the quantitative determination of total antibodies anti-S1 SARS-CoV-2
virus as an aid in the determination of the immune reaction to SARS-CoV-2 or to the vaccine

36 tests 81408

Diesse Press Release

Rassegna stampa

Social Media

Video, dirette streaming e interviste

Diesse Diagnostica

Diesse Diagnostica Senese SpA is an Italian company with integrated and entirely in-house production of in vitro diagnostic systems. Its headquarters are in Siena. Since its foundation in 1980, the company has developed, produced and marketed innovative diagnostic systems primarily in the field of immunodiagnostics and automatic measurement of erythrocyte sedimentation rate (ESR). The company has a global presence in over 100 countries, three production sites and a research centre where the design and implementation of tests and new automated diagnostic detection tools meet Italian design and cutting-edge technology, making Diesse synonymous with "Diagnostics Evolution".

Medialist

Newsletter per giornalisti e media: